Based on genomic analysis of 59 NF1-associated glioma samples from pediatric and adult patients, HGGs were frequently found to have higher mutational burdens with abnormalities in TP53 and CDKN2A, along with inactivation of ATRX, which appears to correlate with more aggressive clinical behavior [89,90]. The gene discussed is NF1; the disease is glioma.